Chemoinformaics analysis of 4-METHYL-PYRIDINE
| Molecular Weight | 93.129 | nRot | 0 |
| Heavy Atom Molecular Weight | 86.073 | nRig | 6 |
| Exact Molecular Weight | 93.0578 | nRing | 1 |
| Solubility: LogS | 0.723 | nHRing | 1 |
| Solubility: LogP | 1.189 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 14 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 15.7876 |
| nHD | 0 | BPOL | 8.16245 |
| QED | 0.472 |
| Synth | 1.582 |
| Natural Product Likeliness | -1.311 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.004 |
| HIA | 0.004 |
| CACO-2 | -4.014 |
| MDCK | 0.0000389 |
| BBB | 0.788 |
| PPB | 0.384415 |
| VDSS | 1.577 |
| FU | 0.677705 |
| CYP1A2-inh | 0.945 |
| CYP1A2-sub | 0.521 |
| CYP2c19-inh | 0.835 |
| CYP2c19-sub | 0.77 |
| CYP2c9-inh | 0.21 |
| CYP2c9-sub | 0.317 |
| CYP2d6-inh | 0.477 |
| CYP2d6-sub | 0.389 |
| CYP3a4-inh | 0.454 |
| CYP3a4-sub | 0.409 |
| CL | 11.469 |
| T12 | 0.762 |
| hERG | 0.032 |
| Ames | 0.068 |
| ROA | 0.865 |
| SkinSen | 0.925 |
| Carcinogencity | 0.362 |
| EI | 0.996 |
| Respiratory | 0.782 |
| NR-Aromatase | 0.039 |
| Antiviral | No |
| Prediction | 0.901349 |